Net Cash Provided by (Used in) Financing Activities in USD of Tengjun Biotechnology Corp. from Q1 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Tengjun Biotechnology Corp. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q1 2011 to Q1 2023.
  • Tengjun Biotechnology Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $2,015,176, a 957% increase year-over-year.
  • Tengjun Biotechnology Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,776,551, a 106% increase from 2021.
  • Tengjun Biotechnology Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $860,718, a 45% increase from 2020.
  • Tengjun Biotechnology Corp. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $591,635, a 1387% increase from 2019.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Tengjun Biotechnology Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $2,015,176 +$1,824,460 +957% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $190,716 -$108,268 -36% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $298,984 +$278,770 +1379% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q1 2020 $20,214 +$449 +2.3% 01 Jan 2020 31 Mar 2020 10-Q 16 Apr 2021 2021 Q1
Q1 2019 $19,765 +$293 +1.5% 01 Jan 2019 31 Mar 2019 10-Q 22 Apr 2020 2020 Q1
Q1 2018 $19,472 +$1,921 +11% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q1 2017 $17,551 +$14,201 +424% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q1 2016 $3,350 -$13,796 -80% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $17,146 -$39,954 -70% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q1 2014 $57,100 +$54,100 +1803% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $3,000 01 Jan 2013 31 Mar 2013 10-Q 04 Jun 2014 2014 Q1
Q1 2011 $13,750 01 Jan 2011 31 Mar 2011 10-Q 19 Apr 2012 2012 Q1

Tengjun Biotechnology Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,776,551 +$915,833 +106% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023 2022 FY
2021 $860,718 +$269,083 +45% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $591,635 +$551,843 +1387% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $39,792 +$9,352 +31% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2021 2020 FY
2018 $30,440 -$1,373 -4.3% 01 Jan 2018 31 Dec 2018 10-K 28 Feb 2020 2019 FY
2017 $31,813 -$10,561 -25% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $42,374 -$21,597 -34% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2018 2017 FY
2015 $63,971 -$5,806 -8.3% 01 Jan 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY
2014 $69,777 +$17,634 +34% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $52,143 01 Jan 2013 31 Dec 2013 10-K 14 Apr 2015 2014 FY
2011 $15,145 01 Jan 2011 31 Dec 2011 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.